J. Ostermann

Posaconazole prophylaxis – impact on incidence of invasive fungal disease and antifungal treatment in haematological patients

H. Ostermann, L. Peterson, C. Rieger, 2013, Mycoses.

Cost evaluation of an innovative outreach clinic across social insurance codes in rural Northern Germany - A routine data analysis.

A. Berghöfer, J. Ostermann, J. Schwarz, 2019, Health & social care in the community.

Can Additional Homeopathic Treatment Save Costs? A Retrospective Cost-Analysis Based on 44500 Insured Persons

T. Reinhold, C. Witt, J. Ostermann, 2015, PloS one.

Etoposide in patients with previously untreated non-small-cell lung cancer: a phase I study

N. Niederle, C. Schmidt, L. Lenaz, 2004, Cancer Chemotherapy and Pharmacology.

A retrospective cost-analysis of additional homeopathic treatment in Germany: Long-term economic outcomes

T. Reinhold, C. Witt, J. Ostermann, 2017, PloS one.

Opinions on Kampo and reasons for using it – results from a cross-sectional survey in three Japanese clinics

C. Witt, T. Seki, Kenji Watanabe, 2013, BMC Complementary and Alternative Medicine.

[Descriptive Analysis of Health Economics of Intensive Home Care of Ventilated Patients].

T. Reinhold, M. Ewers, J. Ostermann, 2018, Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)).